TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Horvitz Wins BMS Award In Neuroscience; Group Room To Discuss Congressional Issues. February 22, 2002
TCL Archive In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three March 12, 1976
TCL Archive Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever October 31, 2014
